Beam Therapeutics Inc. SEC filings BEAM
Beam Therapeutics Inc. has 514 filings in SEC EDGAR's recent list, going back to Aug 9, 2018. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 17, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 5, 2026 | Mar 2, 2026 |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 12, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 11, 2025 | Dec 8, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jul 3, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 18, 2025 | — |
| DEF 14A | Proxy statement | Apr 18, 2025 | Jun 4, 2025 |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| FWP | Free writing prospectus | Mar 10, 2025 | — |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2024 | Dec 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 4, 2024 | Dec 2, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 19, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 19, 2024 | — |
| DEF 14A | Proxy statement | Apr 19, 2024 | Jun 5, 2024 |
| S-3ASR | Automatic shelf registration | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2023 | Dec 13, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Other events
|
Oct 31, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
Oct 19, 2023 | Oct 18, 2023 |
| UPLOAD | Letter from the SEC | Oct 12, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2023 | — |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 424B5 | Prospectus supplement | May 10, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 10, 2023 | May 10, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Other events
|
Sep 7, 2022 | Sep 2, 2022 |
| 8-K |
Current report
Other events
|
Aug 30, 2022 | Aug 25, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 8, 2022 |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 9, 2022 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 8, 2021 | Nov 5, 2021 |
| 10-Q | Quarterly report | Aug 10, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 424B5 | Prospectus supplement | Jul 7, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 7, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2021 | Jun 9, 2021 |
| S-3ASR | Automatic shelf registration | Jun 10, 2021 | — |
| 8-K |
Current report
Officer or director change
|
May 24, 2021 | May 20, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2021 | Apr 22, 2021 |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 9, 2021 |
| 424B5 | Prospectus supplement | Apr 1, 2021 | — |
| 8-K |
Current report
Other events
|
Apr 1, 2021 | Apr 1, 2021 |
| 424B7 | Filing | Apr 1, 2021 | — |
| 424B7 | Filing | Apr 1, 2021 | — |
| S-3ASR | Automatic shelf registration | Apr 1, 2021 | — |
| S-8 | Employee stock plan registration | Mar 17, 2021 | — |
| 10-K | Annual report | Mar 15, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 23, 2021 | Feb 22, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 19, 2021 | Jan 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 11, 2021 | Jan 10, 2021 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 424B4 | Prospectus | Oct 1, 2020 | — |
| EFFECT | Filing | Sep 30, 2020 | — |
| CORRESP | Letter to the SEC | Sep 28, 2020 | — |
| CORRESP | Letter to the SEC | Sep 28, 2020 | — |
| S-1 | Registration statement | Sep 28, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2020 | — |
| DRS | Filing | Sep 18, 2020 | — |
| DRSLTR | Filing | Sep 18, 2020 | — |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2020 | Jun 29, 2020 |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 10-K | Annual report | Mar 30, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2020 | Mar 30, 2020 |
| S-8 | Employee stock plan registration | Feb 24, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 11, 2020 | Feb 10, 2020 |
| 424B4 | Prospectus | Feb 7, 2020 | — |
| EFFECT | Filing | Feb 5, 2020 | — |
| S-1MEF | Filing | Feb 5, 2020 | — |
| S-1/A | Amended registration statement | Feb 5, 2020 | — |
| CERT | Filing | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 3, 2020 | — |
| 8-A12B | Filing | Jan 31, 2020 | — |
| S-1/A | Amended registration statement | Jan 31, 2020 | — |
| CORRESP | Letter to the SEC | Jan 30, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2020 | — |
| S-1/A | Amended registration statement | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 17, 2020 | — |
| S-1/A | Amended registration statement | Jan 17, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2019 | — |
| SEC STAFF LETTER | Filing | Oct 4, 2019 | — |
| CORRESP | Letter to the SEC | Oct 2, 2019 | — |
| CORRESP | Letter to the SEC | Sep 27, 2019 | — |
| S-1 | Registration statement | Sep 27, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2019 | — |
| DRS/A | Filing | Sep 9, 2019 | — |
| DRSLTR | Filing | Sep 6, 2019 | — |
| SEC STAFF LETTER | Filing | Aug 26, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2019 | — |
| DRS | Filing | Jul 29, 2019 | — |
| DRSLTR | Filing | Jul 26, 2019 | — |
| D | Filing | Mar 26, 2019 | — |
| D/A | Filing | Mar 26, 2019 | — |
| D | Filing | Aug 9, 2018 | — |
Showing 174 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BEAM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1745999
- Former names
- Beam Therapeutics Inc. (until Nov 3, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.